Pille und Krebsrisiko: Kontraindikation vs. Chemoprävention

Medicine and Dentistry

• Cancer Risk 100%
• Chemoprophylaxis 100%
• Contraceptive Agent 100%
• Contraindication 100%
• Meta-Analysis 66%
• Malignant Neoplasm 66%
• Breast Cancer 66%
• Risk Reduction 66%
• Ovarian Cancer 66%
• Oral Contraceptive Agent 66%
• Diseases 66%
• Neoplasm 33%
• Cardiovascular Risk 33%
• Cervical Cancer 33%
• Medical History 33%
• Thromboembolism 33%
• Hormonal Contraception 33%
• Colon Carcinoma 33%
• Contraceptive Behavior 33%
• Uterine Cancer 33%
• Side Effect 33%

Keyphrases

• Cancer Risk 100%
• Chemoprevention 100%
• Hormonal Contraception 100%
• Risk Reduction 40%
• Meta-analysis 40%
• Cervical Cancer 40%
• Ovarian Cancer 40%
• Duration of Use 40%
• Germany 20%
• Significant Risk Factors 20%
• Uniform Data Set 20%
• Thromboembolic Risk 20%
• Cardiovascular Risk 20%
• Malignant Disease 20%
• Colon Cancer 20%
• Medical History 20%
• Clinical High Risk 20%
• Puberty 20%
• Breast Cancer Risk 20%
• Combined Oral Contraceptives 20%
• National Guidelines 20%
• International Guidelines 20%
• Endometrial Cancer 20%
• Genetic Disposition 20%
• Risk Modification 20%
• Contraception 20%
• Low-side 20%
• Breast Cancer mutations 20%
• Hormone-dependent Diseases 20%
• Contraceptive Methods 20%
• Contraceptive Use 20%
• Sensitive Phase 20%
• Hormone-sensitive 20%
• Hormone-dependent Cancer 20%
• Contraceptive Safety 20%
• Current Users 20%
• Art Information 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Contraceptive Agent 100%
• Malignant Neoplasm 66%
• Ovary Cancer 66%
• Breast Cancer 66%
• Oral Contraceptive Agent 66%
• Diseases 66%
• Medical History 33%
• Uterine Cervix Cancer 33%
• Colon Carcinoma 33%
• Cardiovascular Risk 33%
• Thromboembolism 33%
• Endometrium Cancer 33%
• Neoplasm 33%
• Side Effect 33%